Sulfacetamide Sodium Lotion
NDC Package 45802-896-26
Package Information
Sulfacetamide Sodium lotions is a medication used to treat bacterial eye infections (such as conjunctivitis). This formulation utilizes a lotion delivery system. Marketed by Padagis Israel Pharmaceuticals Ltd, this product is identified by NDC 45802-896 and is authorized under FDA application ANDA078649.
Identification & Billing
- RxCUI: 1006688 - sulfacetamide sodium 10 % Topical Lotion
- RxCUI: 1006688 - sulfacetamide sodium 100 MG/ML Topical Lotion
- RxCUI: 1006688 - sulfacetamide sodium 10 % Topical Suspension
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 45802 - Padagis Israel Pharmaceuticals Ltd
- 45802-896 - Sulfacetamide Sodium
- 45802-896-26 - 118 mL in 1 BOTTLE, PLASTIC
- 45802-896 - Sulfacetamide Sodium
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 45802-896-26 identifies a specific commercial package of 118 ml in 1 bottle, plastic of Sulfacetamide Sodium, a human prescription drug labeled by Padagis Israel Pharmaceuticals Ltd. This lotion is formulated for topical use and contains sulfacetamide sodium as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Padagis Israel Pharmaceuticals Ltd on October 17, 2012. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used to treat bacterial eye infections (such as conjunctivitis). It belongs to a class of drugs known as sulfa antibiotics. Sulfacetamide works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness.
How is this Padagis Israel Pharmaceuticals Ltd product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 45802089626. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 118 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.